Trending Now
Qualigen Therapeutics (QLGN) Secures New Financing to Propel Growth
In a significant development, Qualigen Therapeutics Inc. (NASDAQ: QLGN), a clinical-stage biopharmaceutical company, saw a dramatic surge in its stock prices following...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Ampio Pharmaceutical Inc. (NYSEAMERICAN:AMPE) Advance Inhaled Ampion Study To Third Group...
Ampio Pharmaceutical Inc. (NYSEAMERICAN:AMPE) has announced that the third group in its Phase 1 inhaled Ampion™ clinical trial is receiving treatment after clearance by...
MAKE IT MODERN
LATEST REVIEWS
Trevena Inc (NASDAQ:TRVN) Collaborates with Imperial College London to Conduct a...
The presence of COVID-19 continues to be one of the trending topics across the world. However, efforts to bring forth a potential vaccine are...
MAKE IT MODERN
PERFORMANCE TRAINING
Market make plummet before the MLK day
Markets opened higher to start the day but faded a little bit to midday. Notably, the SPY never made an hourly close...
Recent Stock Ratings: Insights from Top Financial Firms (CVS,DT,SE,HE,PTON)
In the fast-evolving stock market, premier financial institutions diligently analyze companies to make judicious decisions. Here are some of the recent ratings...
Senti Biosciences (SNTI) Secures $8 Million Grant to Advance Groundbreaking Cancer Treatment
In a significant advancement for cancer therapy, Senti Biosciences, Inc. (NASDAQ: SNTI), commonly known as Senti Bio, has received an $8...
DNL151 Selected to Advance into Two Late-Stage Clinical Studies in Parkinson’s disease: Denali Therapeutics...
Denali Therapeutics Inc. (NASDAQ:DNLI) will be advancing its DNL151 into two late-stage studies in Parkinson’s disease. The decision to do so was accelerated by...
Aligos Therapeutics ($ALGS): A Bold Move to Regain Nasdaq Compliance
Aligos Therapeutics, Inc. (ALGS), a clinical-stage biopharmaceutical company focusing on liver and viral diseases, recently executed a 1-for-25 reverse stock split. This...
MAKE IT MODERN
